![Neil Gallagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Gallagher
Direktor/Vorstandsmitglied bei
FOGHORN THERAPEUTICS INC.
Vermögen: - $ am 30.09.2026
Profil
Neil Gallagher is currently an Independent Director at Foghorn Therapeutics, Inc. since 2025.
Formerly, Dr. Gallagher was Director-Clinical Development at Astex Therapeutics Ltd. Dr. Gallagher was an Independent Director at Zymeworks, Inc. from 2024 to 2025.
Dr. Gallagher was President, Head-Research & Development at Syndax Pharmaceuticals, Inc. from 2023 to 2025.
Dr. Gallagher was Chief Medical Officer & Head-Development at AbbVie, Inc. from 2020 to 2023.
Dr. Gallagher was Head-Development, Oncology & Inflammation at Amgen, Inc. from 2016 to 2017.
Dr. Gallagher earned doctorates from the University of Birmingham and Trinity College Dublin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
Aktive Positionen von Neil Gallagher
| Unternehmen | Position | Beginn |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.05.2025 |
Ehemalige bekannte Positionen von Neil Gallagher
| Unternehmen | Position | Ende |
|---|---|---|
| ZYMEWORKS INC. | Direktor/Vorstandsmitglied | 06.11.2025 |
| SYNDAX PHARMACEUTICALS, INC. | Präsident | 12.05.2025 |
| ABBVIE INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2023 |
| AMGEN INC. | Corporate Officer/Principal | 01.10.2017 |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Corporate Officer/Principal | - |
Ausbildung von Neil Gallagher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
